Incorporating Alcohol Pharmacotherapies Into Medical Practice

Sent on August 4, 2009

Additional Resources

Other Recent TIPs

Treatment Improvement Protocol (TIP) 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice provides guidelines for the use of medications in the treatment of alcohol use disorders. Written for physicians and other health care providers, the TIP presents information on the four medications approved by the Food and Drug Administration to treat this disease: acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The TIP describes each medication’s mechanisms of action, proper dosing, side effects and their management, indications and contraindications, and patient management.


	For more information, contact SAMHSA’s Health Information Network or visit SAMHSA's Web site:


			1-877-SAMHSA-7 (English and Spanish/inglés y español)

			SAMHSA's Web Site

			SAMHSA Health Information Network

			eNetwork Archives

TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice

Download Now PDF (940 KB) | Order Free Copy (SMA09-4380)

To order by phone, contact the SAMHSA Health Information Network (SHIN) at 1-877-SAMHSA-7 (1-877-726-4727) (English and Español). Ask for publication order number SMA09-4380. To facilitate placement of your order, please have the publication order number available.

			KAP E-Learning Course: Acamprosate–A New Medication for Alcohol Use Disorders

			TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs (SMA08-4214)

			Substance Abuse Treatment Advisory (Vol. 5, Issue 4), “The Role of Biomarkers in the Treatment of Alcohol Use Disorders,” September 2006 (507 KB)

			Quick Guide for Clinicians Based on TIP 24: A Guide to Substance Abuse Services for Primary Care Clinicians (179 KB)

			TIP 49 Literature Review: Incorporating Alcohol Pharmacotherapies Into Medical Practice: A Review of the Literature (725 KB)

			TIP 50: Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment (SMA09-4381)

			TIP 48: Managing Depressive Symptoms in Substance Abuse Clients During Early Recovery (828 KB)

			TIP 47: Substance Abuse: Clinical Issues in Intensive Outpatient Treatment (BKD551)

Substance Abuse & Mental Health Services Administration
1 Choke Cherry Road | Rockville, MD 20857 | 1-877-SAMHSA-7 (1-877-726-4727) | http://www.samhsa.gov

SAMHSA is a public health agency within the Department of Health and Human Services. The agency is responsible for improving the accountability, capacity, and effectiveness of the Nation's substance abuse prevention, addictions treatment, and mental health services delivery system.

Please do not reply to this email as this email address is for distribution purposes only.